Increased Risk of Genetic and Epigenetic Instability in Human Embryonic Stem Cells Associated with Specific Culture Conditions
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The self-renewal and differentiation capacities of human pluripotent stem cells (hPSCs) make them a promising source of material for cell transplantation therapy, drug development, and studies of cellular differentiation and development. However, the large numbers of cells necessary for many of these applications require extensive expansion of hPSC cultures, a process that has been associated with genetic and epigenetic alterations. We have performed a combinatorial study on both hESCs and hiPSCs to compare the effects of enzymatic vs. mechanical passaging, and feeder-free vs. mouse embryonic fibroblast feeder substrate, on the genetic and epigenetic stability and the phenotypic characteristics of hPSCs. In extensive experiments involving over 100 continuous passages, we observed that both enzymatic passaging and feeder-free culture were associated with genetic instability, higher rates of cell proliferation, and persistence of OCT4/POU5F1-positive cells in teratomas, with enzymatic passaging having the stronger effect. In all combinations of culture conditions except for mechanical passaging on feeder layers, we noted recurrent deletions in the genomic region containing the tumor suppressor gene TP53, which was associated with decreased mRNA expression of TP53, as well as alterations in the expression of several downstream genes consistent with a decrease in the activity of the TP53 pathway. Among the hESC cultures, we also observed culture-associated variations in global gene expression and DNA methylation. The effects of enzymatic passaging and feeder-free conditions were also observed in hiPSC cultures. Our results highlight the need for careful assessment of the effects of culture conditions on cells intended for clinical therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig 4 Chromosome 12 detail in MefEnz. Detailed view of the duplications in chromosome 12 for MefEnz. A. The green areas indicate the regions of duplication that were identified by CNVPartition 3.2.0. The areas that were detected manually rather than by the software are indicated in a scale from grey to black. Estimates of the percentage of the population carrying the duplication were performed using the BAF distance for heterozygous SNPs as described [3]. B. LogR Ratio (LRR) and BAF plots of replicate A of MefEnz showed changes in genetic aberrations over time. C. The CNV data were further validated via TaqMan Copy Number Assays. Probe 1 corresponds to Hs03295596_cn, Probe 2 to Hs04404518_cn, Probe 3 to Hs03812366_cn, Probe 4 to Hs03841181_cn, Probe 5 to Hs06947059_cn, and Probe 6 to Hs06363301_cn. D. Karyotyping results confirmed the CNV data.](https://figures.cochat.ai/paper-figures/1571f5b4a88f448b827c4e9c56e2c374/increased-risk-of-genetic-and-epigenetic-instability-in-human-embryonic-stem-figure-4.jpg)



![Fig 8 DNA Methylation. A. X Chromosome DNA Methylation and XIST Expression. Methylation levels of genes in the X-chromosome (S6A Table) are shown on the heatmap. Hierarchical clustering was performed on the samples, as indicated by the dendrogram. The genes are ordered according to their location (from the beginning to the end of the chromosome). Samples that show loss of DNA methylation for the “Enz” cluster are highlighted in blue, those that show DNA methylation for the “Ecm” cluster are highlighted in pink, and for both clusters in mauve. Genes located in the regions of loss of DNA methylation are listed to the right of the heatmap. XIST expression is shown on the line graph, with the detection limit for the microarray indicated by the red line. B. DNA methylation at imprinted loci. Methylation levels for imprinted probes (S6B Table) are shown on the heatmap. Hierarchical clustering was performed on the samples, as indicated by the dendrogram. The genes are ordered according to chromosome location; genes are listed to the left. The inset at the right shows a detail of the NESP/GNAS complex locus, indicating the positions of the CpG sites that were hypermethylated (red triangle) vs. hypomethylated (green triangle) in the late passage samples relative to the NESP/GNAS and NESPAS exons. C, D, E. Heatmaps showing differential DNA methylation genes for early vs. late passage (C), mechanical vs. enzymatic passage (D), and Mef vs. Ecm substrate (E). In heatmap (C), the black boxes indicate genes for which the DNA methylation levels in the late passage MefMech (P103) samples was more similar to those in the early passage samples. Probes were selected by multivariate regression. Functional enrichments identified by GREAT analysis are shown to the right of the heatmaps, visualized using REVIGO [13]. Samples were arranged according to passage and culture method, and hierarchical clustering was performed on the genes only. In the functional enrichment results, the size of the node indicated the number of contributing GO terms, and color of the nodes indicates the FDR (darker color for lower FDR), and the edge length indicates the similarity between GO terms (shorter edge for more similar terms).](https://figures.cochat.ai/paper-figures/7b4cd5bcf4c148efbc9443ce7db36da4/increased-risk-of-genetic-and-epigenetic-instability-in-human-embryonic-stem-figure-8.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, the negative impact of enzymatic versus mechanical passaging was also observed in iPSC cultures with an MEF layer.”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although the mutational burden comes mostly from starting cells, the cell culture, passaging reagents, and passaging method could impact the mutational rate [13,14,15,54,55].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a long-term study with more than 100 passages of iPSCs, a group of researchers found that enzymatic passaging caused a higher growth rate, and more genetic instability and OCT4-positive cells in teratoma compared to mechanical passaging [54].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a long-term study with more than 100 passages of iPSCs, a group of researchers found that enzymatic passaging caused a higher growth rate, and more genetic instability and OCT4-positive cells in teratoma compared to mechanical passaging [54].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a long-term study with more than 100 passages of iPSCs, a group of researchers found that enzymatic passaging caused a higher growth rate, and more genetic instability and OCT4-positive cells in teratoma compared to mechanical passaging [54].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [54]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
REVIGO summarizes and visualizes long lists of gene ontology terms
Supek, F., Bošnjak, M., Škunca, N., & Šmuc, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021800 · Cited by 6,264 · cited 1×
“Pathway analysis was performed using GREAT [12], and visualized using REVIGO [13].”
MethodGREAT improves functional interpretation of cis-regulatory regions
McLean, C. Y., Bristor, D., Hiller, M., Clarke, S. L., Schaar, B. T., Lowe, C. B., Wenger, A. M., & Bejerano, G. (2010) · Nature Biotechnology · doi:10.1038/nbt.1630 · Cited by 4,502
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative
Initiative, T. I. S. C. (2007) · Nature Biotechnology · doi:10.1038/nbt1318 · Cited by 1,073
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells
Draper, J. S., Smith, K., Gokhale, P., Moore, H. D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T. P., Thomson, J. A., & Andrews, P. W. (2004) · Nature Biotechnology · doi:10.1038/nbt922 · Cited by 1,021
Copy number variation and selection during reprogramming to pluripotency
Hussein, S. M., Batada, N. N., Vuoristo, S., Ching, R. W., Autio, R., Närvä, E., Ng, S., Sourour, M., Hämäläinen, R., Olsson, C., et al. (2011) · Nature · doi:10.1038/nature09871 · Cited by 954
Cited by
Advanced drug delivery systems and artificial skin grafts for skin wound healing
Kim, H. S., Sun, X., Lee, J.-H., Kim, H.-W., Fu, X., & Leong, K. W. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.014 · Cited by 625
The future of stem cell therapies for Parkinson disease
Parmar, M., Grealish, S., & Henchcliffe, C. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0257-7 · Cited by 306
Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience
Mertens, J., Marchetto, M. C., Bardy, C., & Gage, F. H. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.46 · Cited by 307
Chen, Y., Tristan, C. A., Chen, L., Jovanovic, V. M., Malley, C., Chu, P.-H., Ryu, S., Deng, T., Ormanoglu, P., Tao, D., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01126-2 · Cited by 172
The pluripotent state in mouse and human
Davidson, K. C., Mason, E. A., & Pera, M. F. (2015) · Development · doi:10.1242/dev.116061 · Cited by 179
“Adaptation to single-cell survival is often associated with both epigenetic and characteristic genetic changes (Amps et al., 2011; Garitaonandia et al., 2015), including small amplifications and deletions that might have escaped detection in the studies to date.”
BackgroundThompson, O., von Meyenn, F., Hewitt, Z., Alexander, J. J., Wood, A., Weightman, R., Gregory, S., Krueger, F., Andrews, S., Barbaric, I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15271-3 · Cited by 152
The clinical landscape of CAR NK cells
Jørgensen, L. V., Christensen, E. B., Barnkob, M. B., & Barington, T. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00633-8 · Cited by 164
Rewinding the process of mammalian extinction
Saragusty, J., Diecke, S., Drukker, M., Durrant, B., Friedrich Ben‐Nun, I., Galli, C., Göritz, F., Hayashi, K., Hermes, R., Holtze, S., et al. (2016) · Zoo Biology · doi:10.1002/zoo.21284 · Cited by 126
“genes that inhibit cancerous processes [Garitaonandia et al., 2015].”
BackgroundSelf-citationZhang, H., Badur, M. G., Divakaruni, A. S., Parker, S. J., Jäger, C., Hiller, K., Murphy, A. N., & Metallo, C. M. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.102 · Cited by 117
“Furthermore, culture and passaging conditions as well as time can influence the genetic and epigenetic stability of hPSCs (Laurent et al., 2011; Garitaonandia et al., 2015) or metabolic rates after subculture (Badur et al.”
BackgroundRouhani, F. J., Zou, X., Danecek, P., Badja, C., Amarante, T. D., Koh, G., Wu, Q., Memari, Y., Durbin, R., Martincorena, I., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01147-3 · Cited by 105
The potential of induced pluripotent stem cell derived hepatocytes
Hannoun, Z., Steichen, C., Dianat, N., Weber, A., & Dubart‐Kupperschmitt, A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.025 · Cited by 113
“Undeniably, in comparison with mechanical passaging, enzymatic dissociation was shown to be more deleterious for the cell genome [186]”
BackgroundMantle, J. L., Min, L., & Lee, K. H. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00818 · Cited by 86
Cell culture‐derived extracellular vesicles: Considerations for reporting cell culturing parameters
Shekari, F., Alibhai, F. J., Baharvand, H., Börger, V., Bruno, S., Davies, O. G., Giebel, B., Gimona, M., Salekdeh, G. H., Jaular, L. M., et al. (2023) · Journal of Extracellular Biology · doi:10.1002/jex2.115 · Cited by 106
“For example, human embryonic stem cells experienced genetic instability based on the sub-culturing method (Bai et al., 2015; Garitaonandia et al., 2015).”
BackgroundHigher-Density Culture in Human Embryonic Stem Cells Results in DNA Damage and Genome Instability
Jacobs, K., Zambelli, F., Mertzanidou, A., Smolders, I., Geens, M., Nguyen, H. T., Barbé, L., Sermon, K., & Spits, C. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.01.015 · Cited by 82
“There is currently little information in this regard (Garitaonandia et al., 2015; Rodin et al., 2014); future studies will tell whether these environments are indeed capable of providing the pristine cell cultures necessary for cell-based therapies.”
BackgroundAssou, S., Bouckenheimer, J., & De Vos, J. (2018) · Stem Cells · doi:10.1002/stem.2797 · Cited by 81
Kwon, E. M., Connelly, J. P., Hansen, N. F., Donovan, F. X., Winkler, T., Davis, B. W., Alkadi, H., Chandrasekharappa, S. C., Dunbar, C. E., Mullikin, J. C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616035114 · Cited by 76
Tristan, C. A., Ormanoglu, P., Slamecka, J., Malley, C., Chu, P.-H., Jovanovic, V. M., Gedik, Y., Jethmalani, Y., Bonney, C., Barnaeva, E., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.11.004 · Cited by 80
“However, spontaneous differentiation may also occur in adherent cultures after repeated enzymatic passaging (Barbaric et al., 2014; Garitaonandia et al., 2015; Wang et al., 2013), which can be avoided by using enzyme-free approaches such as EDTA.”
BackgroundGonzalez, R., Garitaonandia, I., Poustovoitov, M., Abramihina, T., McEntire, C. R. S., Culp, B., Attwood, J., Noskov, A., Christiansen-Weber, T., Khater, M., et al. (2016) · Cell Transplantation · doi:10.3727/096368916x691682 · Cited by 75
Self-citationGaritaonandia, I., Gonzalez, R., Christiansen-Weber, T., Abramihina, T., Poustovoitov, M., Noskov, A., Sherman, G., Semechkin, A., Snyder, E., & Kern, R. (2016) · Scientific Reports · doi:10.1038/srep34478 · Cited by 79
Self-citationShelton, M., Kocharyan, A., Liu, J., Skerjanc, I. S., & Stanford, W. L. (2015) · Methods · doi:10.1016/j.ymeth.2015.09.019 · Cited by 79
“Both the manner of, and time that pluripotent ES lines spend in culture, also lead to stably inherited changes in the methylation status of imprinted genes and hundreds of potentially significant CpG islands, even while a line appears karyotypically normal [35,36].”
BackgroundTsiapalis, D., & Zeugolis, D. I. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120943 · Cited by 75
Genomic Instability of iPSCs and Challenges in Their Clinical Applications
Yoshihara, M., Oguchi, A., & Murakawa, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-31206-0_2 · Cited by 60
Fedele, S., Collo, G., Behr, K., Bischofberger, J., Müller, S. G., Kunath, T., Christensen, K., Gündner, A. L., Graf, M. R., Jagasia, R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05633-1 · Cited by 56
Yang, X., Chen, D., Sun, Q., Wang, Y., Xia, Y., Yang, J., Lin, C., Dang, X., Cen, Z., Liang, D., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00543-1 · Cited by 71
“Other inevitable non-genetic variations in routine cell culturing, like cell passage number 13 and altered handling of cells among laboratories or individuals 14 – 18 , also contribute to the differentiation variability.”
BackgroundSelf-citationHuman‐Induced Pluripotent Stem Cell Culture Methods Under cGMP Conditions
Rivera, T., Zhao, Y., Ni, Y., & Wang, J. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.117 · Cited by 72
“BASIC PROTOCOL 1 iPSC DISSOCIATION Culture conditions, including cell passaging methods, affect the genetic and epigenetic stability of iPSCs; importantly, enzymatic passaging of iPSCs is associated with increased genomic instability of iPSCs (Garitaonandia et al., 2015).”
BackgroundCulture-induced recurrent epigenetic aberrations in human pluripotent stem cells
Weissbein, U., Plotnik, O., Vershkov, D., & Benvenisty, N. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006979 · Cited by 55
An Improved Two‐Step Protocol for Trophoblast Differentiation of Human Pluripotent Stem Cells
Horii, M., Bui, T., Touma, O., Cho, H. Y., & Parast, M. M. (2019) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.96 · Cited by 48
Self-citationAnderson, N. C., Chen, P.-F., Meganathan, K., Saber, W. A., Petersen, A. J., Bhattacharyya, A., Kroll, K. L., & Şahin, M. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.03.025 · Cited by 52
“Clump passaging and avoidance of enzymatic dissociation when culturing iPSCs is advisable, as dissociation to single cells may select for the best adapted cells, contributing to genomic variation (Bai et al., 2015; Garitaonandia et al., 2015).”
BackgroundEfficient and safe single-cell cloning of human pluripotent stem cells using the CEPT cocktail
Tristan, C. A., Hong, H., Jethmalani, Y., Chen, Y., Weber, C., Chu, P.-H., Ryu, S., Jovanovic, V. M., Hur, I., Voss, T. C., et al. (2023) · Nature Protocols · doi:10.1038/s41596-022-00753-z · Cited by 44
Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders
Gabriel, E., & Gopalakrishnan, J. (2017) · Journal of Visualized Experiments · doi:10.3791/55372 · Cited by 59
Li, Q., Lin, H., Rauch, J., Deleyrolle, L. P., Reynolds, B. A., Viljoen, H. J., Zhang, C., Zhang, C., Gu, L., Wyk, E. V., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21927-4 · Cited by 48
Amir, H., Touboul, T., Sabatini, K., Chhabra, D., Garitaonandia, I., Loring, J. F., Morey, R., & Laurent, L. C. (2017) · Stem Cells · doi:10.1002/stem.2550 · Cited by 42
Self-citationModeling Huntington׳s disease with patient-derived neurons
Mattis, V. B., & Svendsen, C. N. (2015) · Brain Research · doi:10.1016/j.brainres.2015.10.001 · Cited by 42
“These discrepancies in somatic stability may be explained by culturing conditions, as hESCs demonstrate an increased risk of genetic and epigenetic instability with stressful culture conditions (Garitaonandia et al., 2015).”
BackgroundNew Challenge: Mitochondrial Epigenetics?
Štimpfel, M., Jančar, N., & Virant‐Klun, I. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9771-z · Cited by 44
“However, this may pose a challenge because even slight changes in culture conditions can negatively affect epigenetic stability, potentially leading to premalignant transformation [3, 4].”
BackgroundTheka, I., Sottile, F., Cammisa, M., Bonnin, S., Sánchez-Delgado, M., Vicino, U. D., Neguembor, M. V., Arumugam, K., Aulicino, F., Monk, D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37442-5 · Cited by 43
Korody, M. L., Ford, S. M., Nguyen, T. D., Pivaroff, C. G., Valiente-Alandí, Í., Peterson, S. E., Ryder, O. A., & Loring, J. F. (2021) · Stem Cells and Development · doi:10.1089/scd.2021.0001 · Cited by 44
“It is unlikely that the reprogramming itself would have introduced deleterious mutations [47], but since PSCs have un-limited proliferative ability, harmful mutations and copy number variants can arise over time in culture [48–50].”
Self-citationRebuzzini, P., Zuccotti, M., Redi, C. A., & Garagna, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2171-8 · Cited by 35
“Gain of entire chromosomes 12, 17, 20 or, to a lesser extent, 16 and X (particularly in female cell lines) frequently occurs in human ESCs (hESCs) [16–22], representing about 50 % of all aberrations observed [18].”
BackgroundSteichen, C., Hannoun, Z., Luce, E., Hauet, T., & Dubart-Kupperschmitt, A. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i10.729 · Cited by 45
Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Biendarra‐Tiegs, S. M., Secreto, F. J., & Nelson, T. J. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_350 · Cited by 39
Alidadi, M., Barzgar, H., Zaman, M., Paevskaya, O. A., Metanat, Y., Khodabandehloo, E., & Moradi, V. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1491282 · Cited by 41
Netsrithong, R., García-Pérez, L., & Themeli, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1325209 · Cited by 44
Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes
Le, M. N. T., & Hasegawa, K. (2019) · Bioengineering · doi:10.3390/bioengineering6020048 · Cited by 34
“Long-time exposure to ROCK inhibitor was reported to affect the cell metabolism [60] and chromosomal aberration [61,62].”
BackgroundOvercoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies
Nath, S. C., Menendez, L., & Friedrich Ben-Nun, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316929 · Cited by 35
“Although the mutational burden comes mostly from starting cells, the cell culture, passaging reagents, and passaging method could impact the mutational rate [13–15, 54 , 55].”
BackgroundThe tumorigenic potential of pluripotent stem cells: What can we do to minimize it?
Peterson, S. E., Garitaonandia, I., & Loring, J. F. (2016) · BioEssays · doi:10.1002/bies.201670915 · Cited by 37
Self-citationCurrent Developments in the Stable Production of Human Induced Pluripotent Stem Cells
Horiguchi, I., & Kino‐oka, M. (2021) · Engineering · doi:10.1016/j.eng.2021.01.001 · Cited by 30
“Finally, researchers have reported that various factors, including culture medium, substrate, and dissociation methods [45], affect cell characteristics not only in single-passage culture, but also in multiple-passage culture [46].”
BackgroundContiguous erosion of the inactive X in human pluripotency concludes with global DNA hypomethylation
Bansal, P., Ahern, D. T., Kondaveeti, Y., Qiu, C. W., & Pinter, S. F. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109215 · Cited by 30
“Female hPSC samples trace a common path through XCE To assemble a comprehensive view of X chromosome methylation dynamics in human pluripotency, we collated Illumina BeadChip (450K, MethylEpic) data from all suitable hPSC studies in GEO38,40–46.”
MethodBadur, M. G., Zhang, H., & Metallo, C. M. (2015) · Biotechnology Journal · doi:10.1002/biot.201400749 · Cited by 33
“Another recent study also indicated that enzymatic passaging may cause increased genetic instability and differential DNA methylation [6].”
BackgroundResultDirect somatic lineage conversion
Tanabe, K., Haag, D., & Wernig, M. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0368 · Cited by 30
“The other side of this coin, though, is that iPS cells are clearly not immune to accumulating mutations of various kinds when propagated in culture, including point mutations, copy number variations of small and large genomic fragments, and even gross karyotypic abnormalities [73–79].”
BackgroundMore than bad luck: Cancer and aging are linked to replication-driven changes to the epigenome
Minteer, C., Thrush, K. L., González, J. T., Niimi, P., Rozenblit, M., Rozowsky, J., Liu, J., Frank, M., McCabe, T., Sehgal, R., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf4163 · Cited by 25
“We also analyzed a second ESC dataset (42) that reported multiple passaging conditions (enzyme versus mechanical passaging and mouse feeder versus extracellular matrix) and found that drift is sustained even out to passage 161 (fig.”
Method(2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.01.23 · Cited by 25
Growth factor and macromolecular crowding supplementation in human tenocyte culture
Tsiapalis, D., Kearns, S. R., Kelly, J. L., & Zeugolis, D. I. (2021) · Biomaterials and Biosystems · doi:10.1016/j.bbiosy.2021.100009 · Cited by 25
Iworima, D. G., Rieck, S., & Kieffer, T. J. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.21-0161 · Cited by 18
Tesařová, L., Šimara, P., Stejskal, S., & Koutná, I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157974 · Cited by 34
Tv, N., Кашеварова, А. А., Gridina, M. M., Лопаткина, М. Е., Khabarova, A. A., Yakovleva, Y. S., Menzorov, A. G., Minina, Y. A., Pristyazhnyuk, I. E., Vasilyev, S. А., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83399-3 · Cited by 28
Diverging Concepts and Novel Perspectives in Regenerative Medicine
Muraca, M., Piccoli, M., Franzin, C., Tolomeo, A. M., Jurga, M., Pozzobon, M., & Perilongo, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051021 · Cited by 26
“Indeed, it has been reported that the karyotype of human iPSCs can become unstable during prolonged culture in vitro, exhibiting resistance to apoptosis, altered differentiation patterns, and persistent stem cells populations in teratomas [10].”
BackgroundPassage number affects differentiation of sensory neurons from human induced pluripotent stem cells
Cantor, E., Shen, F., Jiang, G., Tan, Z., Cunningham, G. M., Wu, X., Philips, S., & Schneider, B. P. (2022) · Scientific Reports · doi:10.1038/s41598-022-19018-6 · Cited by 29
Enhancing cord blood stem cell-derived NK cell growth and differentiation through hyperosmosis
Wen, W., Chen, X., Shen, X., Li, H.-Y., Zhang, F., Fang, F., & Zhang, X. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03461-x · Cited by 21
“Despite this potential, the differentiation and expansion process typically surpass five weeks, with potential accumulated mutations over cell culture and iPSC passage posing a challenge [15, 16].”
BackgroundNaung, N. Y., Duncan, W., Silva, K. D., & Coates, D. E. (2019) · European Journal Of Oral Sciences · doi:10.1111/eos.12603 · Cited by 22
Laowtammathron, C., Chingsuwanrote, P., Choavaratana, R., Phornwilardsiri, S., Sitthirit, K., Kaewjunun, C., Makemaharn, O., Terbto, P., Waeteekul, S., Lorthongpanich, C., et al. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0866-5 · Cited by 21
Hejrati, N., Wong, R., Khazaei, M., & Fehlings, M. G. (2023) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2023.2245321 · Cited by 22
Metabolic profile and differentiation potential of extraembryonic endoderm-like cells
Gatie, M. I., & Kelly, G. M. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0102-1 · Cited by 22
Cell reprogramming therapy for Parkinson’s disease
Dong, W., Liu, S., Li, S., & Wang, Z. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.390965 · Cited by 22
“It is crucial to characterize the source cells, especially in large cell banks, where the presence of mutations in growth-related genes such as TP53 mutations has been shown (Garitaonandia et al., 2015; Amir et al., 2017; Merkle et al., 2017).”
BackgroundGenotoxic Effects of Culture Media on Human Pluripotent Stem Cells
Bangalore, M. P., Adhikarla, S., Mukherjee, O., & Panicker, M. M. (2017) · Scientific Reports · doi:10.1038/srep42222 · Cited by 21
Label‐free biomarkers of human embryonic stem cell differentiation to hepatocytes
Tsikritsis, D., Shi, H., Wang, Y., Velugotla, S., Sršeň, V., Elfick, A. P. D., & Downes, A. R. (2016) · Cytometry Part A · doi:10.1002/cyto.a.22875 · Cited by 21
“passage numbers rise above 120 will these embryonic stem cells start to lose their ability to selfrenew and differentiate(40).”
BackgroundSelf-citationEthical issues in biomedical use of human embryonic stem cells (hESCs)
Ghosh, D., Mehta, N., Patil, A., & Sengupta, J. (2016) · Journal of Reproductive Health and Medicine · doi:10.1016/j.jrhm.2016.09.002 · Cited by 20
Using MS induced pluripotent stem cells to investigate MS aetiology
Fortune, A. J., Fletcher, J. L., Blackburn, N. B., & Young, K. M. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103839 · Cited by 17
Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research
Krivec, N., Ghosh, M. S., & Spits, C. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.11.013 · Cited by 21
Mishra, S., Kaçin, E., Stamatiadis, P., Franck, S., der Jeught, M. V., Mertes, H., Pennings, G., Sutter, P. D., Sermon, K., Heindryckx, B., et al. (2018) · Molecular Human Reproduction · doi:10.1093/molehr/gay007 · Cited by 18
“identified as a possible cause of the high level of (epi)genomic instability in hPSC (Garitaonandia et al., 2015; Jacobs et al., 2016; Geens and Chuva De Sousa Lopes, 2017).”
Kim, M., & Kino‐oka, M. (2020) · Biotechnology Journal · doi:10.1002/biot.201900314 · Cited by 15
Shrestha, R., Wen, Y., & Tsai, R. (2020) · Current Eye Research · doi:10.1080/02713683.2020.1722180 · Cited by 18
Cell Reprogramming to Model Huntington’s Disease: A Comprehensive Review
Monk, R., & Connor, B. J. (2021) · Cells · doi:10.3390/cells10071565 · Cited by 22
“The use of mouse embryonic cell feeder layers during iPSC propagation reduces the genomic instability that comes with enzymatic dissociation and passaging [93].”
BackgroundPotential Pitfall of Pluripotent Stem Cells
Trounson, A. (2017) · New England Journal of Medicine · doi:10.1056/nejmcibr1706906 · Cited by 15
Dynamic Features of Chromosomal Instability during Culture of Induced Pluripotent Stem Cells
DuBose, C. O., Daum, J. R., Sansam, C. L., & Gorbsky, G. J. (2022) · Genes · doi:10.3390/genes13071157 · Cited by 18
Foggia, V. D., Makwana, P., Ali, R. R., & Sowden, J. C. (2016) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2015.0143 · Cited by 17
Canine induced pluripotent stem cell maintenance under feeder‐free and chemically‐defined conditions
Kimura, K., Tsukamoto, M., Yoshida, T., Tanaka, M., Kuwamura, M., Ohtaka, M., Nishimura, K., Nakanishi, M., Sugiura, K., & Hatoya, S. (2021) · Molecular Reproduction and Development · doi:10.1002/mrd.23478 · Cited by 15
“In contrast, the single‐ cell passage of ESCs or iPSCs has been shown to cause genomic mutations during long‐term culture (Bai et al., 2015; Garitaonandia et al., 2015); therefore, it is necessary to check the karyotype of cells frequently to ensure that the cells retain a normal karyotype.”
BackgroundBorkowska, J., Domaszewska-Szostek, A., Kołodziej, P., Wicik, Z., Połosak, J., Buyanovskaya, O. A., Charzewski, Ł., Stańczyk, M., Noszczyk, B. H., & Puzianowska‐Kuźnicka, M. (2020) · Epigenomics · doi:10.2217/epi-2019-0131 · Cited by 15
Loh, K. M., Zheng, S. L., Liu, K. J., Yin, Q., Amir-Ugokwe, Z. A., Jha, S. K., Qi, Y., Wazny, V. K., Nguyen, A. T., Chen, A. C., et al. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.103494 · Cited by 12
Banerjee, M., Al‐Eryani, L., Srivastava, S., Rai, S. N., Pan, J., Kalbfleisch, T., & States, J. C. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab129 · Cited by 13
Molina-Ruiz, F. J., Introna, C., Bombau, G., Galofré, M., & Canals, J. M. (2022) · Cells · doi:10.3390/cells11131984 · Cited by 15
The Human Induced Pluripotent Stem Cell Test as an Alternative Method for Embryotoxicity Testing
Galanjuk, S., Zühr, E., Dönmez, A., Bartsch, D., Kurian, L., Tigges, J., & Fritsche, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063295 · Cited by 13
“, in the choice of the hiPSC line or the selection of cell culture medium or coating matrix [49].”
BackgroundCapturing the ephemeral human pluripotent state
Ávila‐González, D., García-López, G., García‐Castro, I. L., Flores‐Herrera, H., Molina‐Hernández, A., Portillo, W., & Díaz, N. F. (2016) · Developmental Dynamics · doi:10.1002/dvdy.24405 · Cited by 12
“These findings suggested that, during the derivation process, hESC acquired a specific phenotype and that the developmental stage used to obtain pluripotent cells was not relevant (Giritharan et al., 2011).”
ResultAnderson, A. J., & Cummings, B. J. (2016) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110516667937 · Cited by 11
Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones
Frank, E., Cailleret, M., Nelep, C., Fragner, P., Polentes, J., Herardot, E., Kassar, L. E., Giraud-Triboult, K., Monville, C., & M’Barek, K. B. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03327-2 · Cited by 13
“nanowells Current hPSC culture methods involve passaging as small clumps/aggregates to prevent cell death or cellular stress and to prevent the risk of genetic alterations [11].”
MethodBorys, B. S., Dang, T., Worden, H., Larijani, L., Corpuz, J. M., Abraham, B. D., Gysel, E. J., Malinovska, J., Krawetz, R., Révay, T., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03819-9 · Cited by 11
Lu, V., Doan, M. T., Roy, I. J., Torres, A., & Teitell, M. A. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101568 · Cited by 12
“Differentiated cells must be removed to reduce unwanted genetic aberrations or loss of pluripotency due to poor cell quality and spontaneous differentiation (Garitaonandia et al., 2015).”
BackgroundYoo, D. H., Im, Y. S., Oh, J. Y., Gil, D., & Kim, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-32567-8 · Cited by 13
Cellular Models: HD Patient-Derived Pluripotent Stem Cells
Smith-Geater, C., Hernandez, S. J., Thompson, L. M., & Mattis, V. B. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7825-0_4 · Cited by 11
Dental pulp stem cells in serum‐free medium for regenerative medicine
Coates, D. E., Alansary, M., Friedlander, L. T., Zanicotti, D. G., & Duncan, W. J. (2019) · Journal of the Royal Society of New Zealand · doi:10.1080/03036758.2019.1673447 · Cited by 10
“…expansion of MSCs should not only include the type of serum-free medium but whether cells are passaged by either mechanical/enzymatic means, and the effects of freezing/revival on cells, all of which can cause genetic and epigenetic mutations (Wang et al. 2012; Garitaonandia et al. 2015).”
BackgroundMethodSong, H. W., Solomon, J. N., Masri, F., Mack, A. A., Durand, N., Cameau, E., Dianat, N., Hunter, A. L., Oh, S., Schoen, B., et al. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.05.024 · Cited by 14
Stabilization of hESCs in two distinct substates along the continuum of pluripotency
Dekel, C., Morey, R. E., Hanna, J. H., Laurent, L. C., Ben‐Yosef, D., & Amir, H. (2022) · iScience · doi:10.1016/j.isci.2022.105469 · Cited by 10
Self-citationHoseini, S. M., Montazeri, F., Matin, M. M., Bahrami, A. R., Heidarian-Meimandi, H., Ghasemi‐Esmailabad, S., & Kalantar, S. M. (2020) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v13i10.7773 · Cited by 9
“These findings suggest that it will be important to minimize such phenotypic, genetic and epigenetic instabilities in hMSCs cultures especially in clinical applications (36).”
BackgroundBower, O. J., McCarthy, A., Lea, R. A., Alanis‐Lobato, G., Zohren, J., Gerri, C., Turner, J. M. A., & Niakan, K. K. (2021) · Current Protocols · doi:10.1002/cpz1.232 · Cited by 8
“Additionally, this genomic instability can be exacerbated during the process of CRISPR-Cas9-mediated DNA double-strand breakage and repair, and further by the process of single-cell amplification (Garitaonandia et al., 2015) and the use of Rho kinase (ROCK) inhibitors (Weissbein et al., 2019).”
BackgroundRegenerative Medicine: Looking Backward 10 Years Further On
Kemp, P. D. (2016) · Regenerative Medicine · doi:10.2217/rme-2016-0136 · Cited by 8
Kammers, K., Taub, M. A., Ruczinski, I., Martin, J., Yanek, L. R., Frazee, A. C., Gao, Y., Hoyle, D. L., Faraday, N. R., Becker, D. M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0167794 · Cited by 8
Brenière‐Letuffe, D., Shibamiya, A., Hansen, A., Thomas Eschenhagen, A., Fehse, B., Riecken, K., & Stenzig, J. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0893-2 · Cited by 9
“Recently, however, more and more studies point out iPSC variability depending on multiple factors such as passage number, culture methods, reprogramming technique or origin of the cells, which would explain lab-to-lab and cell-line to cell-line variabilities [8, 24].”
BackgroundResultXeno‐Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin‐521
Skorik, C., Mullin, N. K., Shi, M. A., Zhang, Y., Hunter, P., Tang, Y., Hilton, B. M., & Schlaeger, T. M. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.103 · Cited by 9
“The propensity of human pluripotent stem cells to acquire karyotypic and other genetic abnormalities is low when using mechanical clump passaging methods, but can be significantly elevated when single-cell dissociation methods are used (Buzzard, Gough, Crook, & Colman, 2004; Chan, Yates, Boyer, Schlaeger, & Daley, 200…”
MethodGenomic Stability Testing of Pluripotent Stem Cells
McIntire, E. M., Taapken, S. M., Leonhard, K., & Larson, A. L. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.107 · Cited by 13
Manipulating cell fate while confronting reproducibility concerns
Osterloh, J. M., & Mullane, K. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.016 · Cited by 7
Kim, J., Kwon, E., Kim, Y.-J., Kim, D., Shin, Y.-Z., Gil, D., Kim, J., Shin, H. D., Kim, L. H., Lee, M., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05060-8 · Cited by 6
“As described earlier [41], there were distinct alterations in methylation patterns at CpG sites were observed in hESCs that had been cultured for an extended period (Fig.”
BackgroundMethodInfluentialStelcer, E., Kulcenty, K. I., & Suchorska, W. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205691 · Cited by 7
Metadata
- Authors
- Garitaonandia, I., Amir, H., Boscolo, F. S., Wambua, G. K., Schultheisz, H. L., Sabatini, K., Morey, R., Waltz, S., Wang, Y.-C., Tran, H., Leonardo, T. R., Nazor, K., Slavin, I., Lynch, C., Li, Y., Coleman, R., Gallego Romero, I., Altun, G., Reynolds, D., Dalton, S., Parast, M., Loring, J. F., & Laurent, L. C.
- Affiliations
- Scripps Research Institute (US)
- University of California San Diego (US)
- University of Georgia (US)
- Corresponding author
- Loring, Jeanne F.
- Laurent, Louise C.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-02-25
- Volume
- 10
- Issue
- 2
- Pages
- e0118307
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4340884
- OpenAlex
- W2056795346
- Cited by
- 150
- References
- 25
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 17 · 2023: 16 · 2022: 14 · 2021: 17 · 2020: 13 · 2019: 10 · 2018: 14 · 2017: 15 · 2016: 20 · 2015: 5
- FWCI
- 7.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Knowledge@UChicago (University of Chicago) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- University of Chicago (cc-by)
- Funders
- Autism Speaks
- California Institute for Regenerative Medicine (RT1-01108, CL1‐00502, TG2-01165, TB1-01193, RM1-01717, RN2-00931-1, TR1-01250, 01165)
- Hartwell Foundation
- Wellcome Trust
- National Institutes of Health (GM085354)
- University of California, San Diego
- National Heart, Lung, and Blood Institute (P01HL089471)
- National Institute of Mental Health (R33MH087925)
- National Institute of General Medical Sciences (P01GM085354)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- human embryonic stem cells, induced pluripotent stem cells, genomic instability, epigenetic instability, culture conditions, feeder-free culture, TP53 deletion, teratoma, DNA methylation, global gene expression, cell proliferation, pluripotency
- MeSH terms
- Human Embryonic Stem Cells, Cell Self Renewal, Cell Differentiation, Cell Line, Cell Transformation, Neoplastic, Cells, Cultured, Chromosome Aberrations, Chromosome Deletion, Chromosomes, Human, Pair 12, Chromosomes, Human, Pair 17, Chromosomes, Human, Pair 20, Humans, Phenotype, Time Factors, Genome, Human, Tumor Suppressor Protein p53, Cell Culture Techniques, DNA Methylation, Polymorphism, Single Nucleotide, Gene Expression Profiling, Pluripotent Stem Cells, Genomic Instability, Epigenesis, Genetic, Chromosome Duplication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.